Inductos
dibotermin alfa
Tibial Fractures
Fracture Fixation, Internal
Spinal Fusion
Date of authorisation:
Revision: 23
Last updated:
MedicineHumanAuthorised
BroPair Spiromax
salmeterol
fluticasone propionate
Asthma
Date of authorisation:
Revision: 1
Last updated:
MedicineHumanAuthorised
Seffalair Spiromax
salmeterol
fluticasone propionate
Asthma
Date of authorisation:
Last updated:
MedicineHumanAuthorised
Aerivio Spiromax
salmeterol
fluticasone propionate
Pulmonary Disease, Chronic Obstructive
Asthma
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanWithdrawn
Airexar Spiromax
salmeterol xinafoate
fluticasone propionate
Pulmonary Disease, Chronic Obstructive
Asthma
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanWithdrawn
EMEA-002177-PIP01-17 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Pneumology-allergology
PIP number: P/0245/2017
Route(s) of administration: Inhalation use
Pharmaceutical form(s):
Inhalation powder
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Inductos - referral
dibotermin alfa
Article 20 procedures
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
TruScient
dibotermin alfa
Dogs
Date of authorisation:
Revision: 4
Last updated:
MedicineVeterinaryWithdrawn
Budesonide / salmeterol xinafoate - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Pneumology-allergology
PIP number: P/47/2010
Route(s) of administration: Inhalation use
Pharmaceutical form(s):
Inhalation powder
Capsule (hard)
Decision date:
Last updated:
Compliance check: ✖
PIPHuman